88709-31-3

Basic information

• Product Name: Benzoic acid, 4-(cyanomethyl)-2-methoxy-
• CAS NO: 88709-31-3
• Molecular Formula: C10H9NO3
• Molecular Weight: 191.186
• Mol File: 88709-31-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-(cyanomethyl)-2-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(cyanomethyl)-2-methoxy-(88709-31-3)
• EPA Substance Registry System: Benzoic acid, 4-(cyanomethyl)-2-methoxy-(88709-31-3)

Safety Data

• Hazardous Substances Data: 88709-31-3(Hazardous Substances Data)

Upstream product

• 35633-35-3 2-methoxy-4-methylacetophenone 
• 704-45-0 2-methoxy-4-methylbenzoic acid 
• 122-46-3 3-acetoxytoluene 
• 6921-64-8 4'-hydroxy-2'-methylacetophenone 
• 88709-30-2 4-(bromomethyl)-2-methoxybenzoic acid 
• 151-50-8 potassium cyanide 

Downstream Products

• 90560-45-5 3-Hydroxy-4-carboxy-phenylessigsaeure 
• 708967-62-8 4-(2-aminoethyl)-2-hydroxybenzoic acid 
• 60531-32-0 4-(2-<5-Chloro-2-methoxy-benzamido>-ethyl)-2-methoxybenzoic acid 

Relevant articles and documents

New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture

The present invention relates to carboxamide compounds of general formula I wherein the groups and residues A, B, W, X, Y, Z, R1, R2, R3 and k have the meanings given in claim 1. Moreover the invention relates to process for preparing the above mentioned carboxamides as well as pharmaceutical compositions containing at least one carboxamide according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.